+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hematology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

  • ID: 5292715
  • Report
  • February 2021
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
Hematology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Drugs market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider hematology drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hematology drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Blood Products; Anemia and Other Blood Disorder Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Novo Nordisk A/S; Shire Plc; Bayer AG; Daiichi Sankyo Company; Biogen Inc

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, hematology drugs indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
1. Executive Summary

2. Report Structure

3. Hematology Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Hematology Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Hematology Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Hematology Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Hematology Drugs Market Trends and Strategies

8. Impact of COVID-19 on Hematology Drugs

9. Hematology Drugs Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. Hematology Drugs Market Regional Analysis
10.1. Global Hematology Drugs Market, 2020, by Region, Value ($ Billion)
10.2. Global Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global Hematology Drugs Market, Growth and Market Share Comparison, by Region

11. Hematology Drugs Market Segmentation
11.1. Global Hematology Drugs Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Products
  • Anemia and Other Blood Disorder Drugs
11.2. Global Hematology Drugs Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
11.3. Global Hematology Drugs Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
11.4. Global Hematology Drugs Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
11.5. Global Hematology Drugs Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
12. Hematology Drugs Market Metrics
12.1. Hematology Drugs Market Size, Percentage of GDP, 2015-2025, Global
12.2. Per Capita Average Hematology Drugs Market Expenditure, 2015-2025, Global

13. Asia-Pacific Hematology Drugs Market
13.1. Asia-Pacific Hematology Drugs Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. Asia-Pacific, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
13.3. Asia-Pacific, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
13.4. Asia-Pacific, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
13.5. Asia-Pacific, Hematology Drugs Market Metrics
13.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
13.6. Asia-Pacific Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Hematology Drugs Market: Country Analysis
13.7.1. China Hematology Drugs Market
13.7.1.1. China Hematology Drugs Market Overview
13.7.1.2. China Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.1.3. China Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2. Australia Hematology Drugs Market
13.7.2.1. Australia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Hematology Drugs Market
13.7.3.1. Hong Kong Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4. India Hematology Drugs Market
13.7.4.1. India Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4.2. India Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Hematology Drugs Market
13.7.5.1. Indonesia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6. Japan Hematology Drugs Market
13.7.6.1. Japan Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Hematology Drugs Market
13.7.7.1. Malaysia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Hematology Drugs Market
13.7.8.1. New Zealand Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Hematology Drugs Market
13.7.9.1. Philippines Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Hematology Drugs Market
13.7.10.1. Singapore Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Hematology Drugs Market
13.7.11.1. South Korea Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Hematology Drugs Market
13.7.12.1. Thailand Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Hematology Drugs Market
13.7.13.1. Vietnam Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe Hematology Drugs Market
14.1. Western Europe Hematology Drugs Market Overview
14.2. Western Europe, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
14.3. Western Europe, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Western Europe, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Western Europe, Hematology Drugs Market Metrics
14.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, Western Europe Countries
14.6. Western Europe Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Western Europe Hematology Drugs Market: Country Analysis
14.7.1. Austria Hematology Drugs Market
14.7.1.1. Austria Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Hematology Drugs Market
14.7.2.1. Belgium Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Hematology Drugs Market
14.7.3.1. Denmark Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. Finland Hematology Drugs Market
14.7.4.1. Finland Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. France Hematology Drugs Market
14.7.5.1. France Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. France Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Germany Hematology Drugs Market
14.7.6.1. Germany Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Hematology Drugs Market
14.7.7.1. Ireland Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. Italy Hematology Drugs Market
14.7.8.1. Italy Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Hematology Drugs Market
14.7.9.1. Netherlands Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Norway Hematology Drugs Market
14.7.10.1. Norway Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Hematology Drugs Market
14.7.11.1. Portugal Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Spain Hematology Drugs Market
14.7.12.1. Spain Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Hematology Drugs Market
14.7.13.1. Sweden Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Hematology Drugs Market
14.7.14.1. Switzerland Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15. UK Hematology Drugs Market
14.7.15.1. UK Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe Hematology Drugs Market
15.1. Eastern Europe Hematology Drugs Market Overview
15.2. Eastern Europe, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
15.3. Eastern Europe, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Eastern Europe, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Eastern Europe, Hematology Drugs Market Metrics
15.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, Eastern Europe Countries
15.6. Eastern Europe Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Hematology Drugs Market: Country Analysis
15.7.1. Czech Republic Hematology Drugs Market,
15.7.1.1. Czech Republic Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Poland Hematology Drugs Market
15.7.2.1. Poland Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Romania Hematology Drugs Market
15.7.3.1. Romania Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Russia Hematology Drugs Market
15.7.4.1. Russia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America Hematology Drugs Market
16.1. North America Hematology Drugs Market Overview
16.2. North America, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
16.3. North America, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. North America, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. North America, Hematology Drugs Market Metrics
16.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, North America Countries
16.6. North America Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. North America Hematology Drugs Market: Country Analysis
16.7.1. Canada Hematology Drugs Market
16.7.1.1. Canada Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Hematology Drugs Market
16.7.2.1. Mexico Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. USA Hematology Drugs Market
16.7.3.1. USA Hematology Drugs Market Overview
16.7.3.2. USA Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America Hematology Drugs Market
17.1. South America Hematology Drugs Market Overview
17.2. South America, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
17.3. South America, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. South America, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. South America, Hematology Drugs Market Metrics
17.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, South America Countries
17.6. South America Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. South America Hematology Drugs Market: Country Analysis
17.7.1. Argentina Hematology Drugs Market
17.7.1.1. Argentina Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Hematology Drugs Market
17.7.1.1. Brazil Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. Chile Hematology Drugs Market
17.7.3.1. Chile Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Hematology Drugs Market
17.7.4.1. Colombia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.5. Peru Hematology Drugs Market
17.7.5.1. Peru Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Hematology Drugs Market
17.7.6.1. Venezuela Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East Hematology Drugs Market
18.1. Middle East Hematology Drugs Market Overview
18.2. Middle East, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
18.3. Middle East, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. Middle East, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. Middle East, Hematology Drugs Market Metrics
18.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, Middle East Countries
18.6. Middle East Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. Middle East Hematology Drugs Market: Country Analysis
18.7.1. Saudi Arabia Hematology Drugs Market
18.7.1.1. Saudi Arabia Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Israel Hematology Drugs Market
18.7.2.1. Israel Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Hematology Drugs Market
18.7.3.1. Turkey Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. UAE Hematology Drugs Market
18.7.4.1. UAE Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa Hematology Drugs Market
19.1. Africa Hematology Drugs Market Overview
19.2. Africa, Hematology Drugs Market, 2020, by Country, Value ($ Billion)
19.3. Africa, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Africa, Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Africa, Hematology Drugs Market Metrics
19.5.1. Per Capita Average Hematology Drugs Expenditure, 2015-2025, Africa Countries
19.6. Africa Hematology Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Africa Hematology Drugs Market: Country Analysis
19.7.1. Egypt Hematology Drugs Market
19.7.1.1. Egypt Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Hematology Drugs Market
19.7.2.1. Nigeria Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Hematology Drugs Market
19.7.3.1. South Africa Hematology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Hematology Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Novo Nordisk A/S
20.3.1.1. Company Overview
20.3.1.2. Products and Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Shire Plc
20.3.2.1. Company Overview
20.3.2.2. Products and Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Bayer AG
20.3.3.1. Company Overview
20.3.3.2. Products and Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. Daiichi Sankyo Company
20.3.4.1. Company Overview
20.3.4.2. Products and Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Biogen Inc
20.3.5.1. Company Overview
20.3.5.2. Products and Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers and Acquisitions in the Hematology Drugs Market

22. Market Background: Pharmaceutical Drugs Market
22.1. Pharmaceutical Drugs Market Characteristics
22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global
22.3. Global Pharmaceutical Drugs Market, 2020, by Region, Value ($ Billion)
22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion)

23. Recommendations
23.1. Global Hematology Drugs Market in 2025 - Growth Countries
23.2. Global Hematology Drugs Market in 2025 - Growth Segments
23.3. Global Hematology Drugs Market in 2025 - Growth Strategies

24. Appendix
24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Bayer AG
  • Biogen Inc
  • Daiichi Sankyo Company
  • Novo Nordisk A/S
  • Shire Plc
  • MORE
Major companies in the hematology drugs market include Novo Nordisk A/S; Shire Plc; Bayer AG; Daiichi Sankyo Company and Biogen Inc.

The global hematology drugs market is expected to grow from $78.83 billion in 2020 to $82.57 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $119.92 billion in 2025 at a CAGR of 10%.

The hematology drugs market consists of sales of hematology drugs and related services by entities (organizations, sole traders and partnerships) that produce hematology drugs to treat diseases such as genetic disorders, anemia, and other related diseases. This industry includes establishments that produce blood products such as red blood cells, white blood cells, platelets, and fresh frozen plasma. It also consists of establishments which produce of anemia and other blood disorder drugs to treat anemia, hemophilia and blood clots. The hematology drugs market is segmented into blood products; and anemia and other blood disorder drugs.

Asia Pacific was the largest region in the global hematology drugs market, accounting for 36% of the market in 2020. North America was the second largest region accounting for 27% of the global hematology drugs market. Africa was the smallest region in the global hematology drugs market.

Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its low price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. According to the World Maternal Antifibrinolytic (WOMAN) trial conducted in April 2017, using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%. The trial included over 20,000 women from 193 hospitals in 21 countries.

Regulatory agencies and federal governments adopted stringent regulations and took a tough stance on drug pricing by pharmaceutical companies during the historic period. Pharmaceutical companies faced criticism from politicians, patients and physicians over high pricing of some medicines and drugs. Moreover, companies had to sell drugs and medicines at subsidized rates to government hospitals, doctors and clinics, further effecting companies’ revenues. This led to drug manufacturing companies operating on a reduced profit margin, which negatively impacted the attractiveness of the hematology drugs industry in the historic period.

The hematology drugs market growth is aided by stable economic growth forecasted in many developed and developing countries. The International Monetary Fund (IMF) predicts that the global GDP growth will be 3.3% in 2020 and 3.4% in 2021. Recovering commodity prices, after a significant decline in the historic period is further expected to aid the market growth. Developed economies are also expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than the developed markets in the forecast period. This is expected to increase spending on healthcare services, thereby driving the demand for hematology drugs.
Note: Product cover images may vary from those shown
4 of 5
  • Novo Nordisk A/S
  • Shire Plc
  • Bayer AG
  • Daiichi Sankyo Company
  • Biogen Inc
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll